MORF Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Morphic Holding Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 29.9 USD 4.14%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast MORF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MORF is 57.12 USD with a low forecast of 30.3 USD and a high forecast of 73.5 USD.

MORF Lowest Forecast

Wall Street Target

MORF Average Forecast

Wall Street Target

MORF Highest Forecast

Wall Street Target

1% Upside

91% Upside

146% Upside

The latest public price target was made on Mar 13, 2024 by Michael Yee from Jefferies , who expects MORF stock to rise by 101% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Michael Yee Jefferies	60 USD Upside 101%	1 month ago Mar 13, 2024	Morphic Therapeutic (MORF) PT Raised to $60 at Jefferies StreetInsider

Price Target	60 USD
Upside/Downside	101%

Arbutus Biopharma Corp

66% Upside

Mineralys Therapeutics Inc

166% Upside

Beijing Leadman Biochemistry Co Ltd

264% Upside

Ovid Therapeutics Inc

158% Upside

Arbutus Biopharma Corp

66% Upside

Mineralys Therapeutics Inc

166% Upside

Beijing Leadman Biochemistry Co Ltd

264% Upside

Ovid Therapeutics Inc

158% Upside

Krystal Biotech Inc

19% Upside

Panacea Biotec Ltd

51% Downside

Ascendis Pharma A/S

34% Upside

Sera Prognostics Inc

75% Downside

Revenue
Forecast

For the last 5 years the compound annual growth rate for Morphic Holding Inc's revenue is -31%. The projected CAGR for the next 3 years is -8%.

-31%

-8%

-4%

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

1%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-36%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for MORF is 57.12 USD with a low forecast of 30.3 USD and a high forecast of 73.5 USD.

For the last 5 years the compound annual growth rate for Morphic Holding Inc's revenue is -31%. The projected CAGR for the next 3 years is -8%.

Join more than 134,000+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.